» Articles » PMID: 18452218

Synchronous and Metachronous Cancers in Patients with Gastric Cancer

Overview
Journal J Surg Oncol
Date 2008 May 3
PMID 18452218
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: The purpose of this study is to investigate characteristics of synchronous and metachronous cancer in gastric cancer and to suggest appropriate methods of treatment management.

Methods: We reviewed 4,593 patients who underwent operations for gastric cancer at Seoul National University Hospital from 1999 to 2005. We selected those patients who had also been diagnosed with another primary cancer and classified patients into three groups according to the date of detection of another primary cancer. We analyzed their clinicopathological features.

Results: The incidence of synchronous or metachronous cancer in addition to gastric cancer was 3.4%. The most common another primary cancer was colorectal cancer (20.1%), followed by lung cancer and liver cancer. The majority of synchronous cancers were operated on at the same time as gastric cancer. Eighty-five percent of the synchronous group and 45% of the post-metachronous group were detected by a routine checkup, without prior symptoms. There was no postoperative mortality and the overall 5-year survival rate was 69.4%.

Conclusion: Synchronous cancer should be considered in the preoperative workup and combined resection should be applied whenever possible. Periodic examination for metachronous cancer is necessary during the postoperative period.

Citing Articles

Deciphering the risk of developing liver cancer following gastric cancer diagnosis with genetic evidence: a Mendelian randomization analysis in an East Asian population.

Chen J, Zeng A, Yu Y, Liao L, Huang S, Sun S Discov Oncol. 2025; 16(1):166.

PMID: 39937324 PMC: 11822172. DOI: 10.1007/s12672-025-01938-0.


The Bidirectional Impact of Cancer Radiotherapy and Human Microbiome: Microbiome as Potential Anti-tumor Treatment Efficacy and Toxicity Modulator.

Palkovsky M, Modrackova N, Neuzil-Bunesova V, Liberko M, Soumarova R In Vivo. 2024; 39(1):37-54.

PMID: 39740900 PMC: 11705129. DOI: 10.21873/invivo.13803.


Synchronous Gastric and Rectal Adenocarcinoma With Complete Response After Total Neoadjuvant Therapy: A Case Report.

Martins D, Marques R, Martins D, Melo A, Pinto-de-Sousa J Cureus. 2024; 16(5):e60787.

PMID: 38903319 PMC: 11188006. DOI: 10.7759/cureus.60787.


Retrospective cohort study investigating association between precancerous gastric lesions and colorectal neoplasm risk.

Pan H, Zhang Y, Fang C, Chen Y, He L, Zheng X Front Oncol. 2024; 14:1320020.

PMID: 38444677 PMC: 10914248. DOI: 10.3389/fonc.2024.1320020.


Influence of pancreaticoduodenectomy for periampullary carcinoma on intestinal microbiome and metabolites.

Fang J, Xiao C, Qi Y, Hong W, Wang M Heliyon. 2024; 10(2):e24393.

PMID: 38304782 PMC: 10831615. DOI: 10.1016/j.heliyon.2024.e24393.